Pharmaceutical composition for prevention or treatment of virus infection, the pharmaceutical composition comprising rottlerin as active ingredient

Abstract

The present disclosure relates to a pharmaceutical composition comprising rottlerin as an active ingredient for the prevention or treatment of a virus infection. The pharmaceutical composition of the present disclosure for the prevention or treatment of a virus infection comprising rottlerin as an active ingredient can be advantageously used to treat a virus infection caused by coronavirus, porcine epidemic diarrhea virus, transmissible gastroenteritis virus, porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, or the like.

Dependencies are inferred from the claim text.